# Commission Regulation (EC) No 1729/2006 of 23 November 2006 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards firocoxib and triclabendazole (Text with EEA relevance), Division 2.1.3: Benzimidazoles and pro-benzimidazoles

Extent: E+W+S+N.I.

Not for use in animals producing milk for human consumption.’
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
‘Triclabendazole
Sum of extractable residues that may be oxidised to ketotriclabendazole
All ruminants
225 μg/kg
Muscle
100 μg/kg
Fat
250 μg/kg
Liver
150 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2006/1729/annex/division/A/division/2/division/2.1/division/2.1.3 (the official version)
Page: https://openlegislation.uk/eu-regulation-2006-1729/annex/division-A/division-2/division-2.1/division-2.1.3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.